Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: an analysis of 181 patients of the French ATU compassionate use program.
about
Management Strategies in Advanced Uterine Leiomyosarcoma: Focus on TrabectedinBRCA1 haplotype and clinical benefit of trabectedin in soft-tissue sarcoma patientsA comprehensive safety evaluation of trabectedin and drug-drug interactions of trabectedin-based combinations.Trabectedin for inoperable or recurrent soft tissue sarcoma in adult patients: a retrospective cohort study.Prognostic factors predicting the postoperative survival period following treatment for primary retroperitoneal liposarcoma.Update on the role of trabectedin in the treatment of intractable soft tissue sarcomasSafety evaluation of trabectedin in treatment of soft-tissue sarcomas.Going further in the knowledge of Yondelis®; what's new in daily clinical practice?Soft tissue sarcomas, a look into the future: different treatments for different subtypes.The indications and efficacy of conventional chemotherapy in primary and recurrent sarcoma.Review of past and present clinical cases with a view to future treatment options.The safety and efficacy of trabectedin for the treatment of liposarcoma or leiomyosarcoma.Trabectedin for the treatment of soft tissue sarcomas.Pharmacological therapies for Liposarcoma.Newer medical therapies for metastatic soft tissue sarcoma.Efficacy and safety of trabectedin as an early treatment for advanced or metastatic liposarcoma and leiomyosarcoma.Trabectedin for sarcomas in daily clinical practice: analysis of 45 patients treated in a French institution.Complete response after rechallenge with trabectedin in a patient with previously responding high-grade undifferentiated sarcoma.The Austrian experience with trabectedin in non-selected patients with metastatic soft tissue sarcoma (STS).Feasibility and clinical value of CT-guided (125)I brachytherapy for metastatic soft tissue sarcoma after first-line chemotherapy failure.Trabectedin’s contribution to the treatment of sarcomas
P2860
Q28087771-C4B4CE29-6795-4827-8B99-D75530CA7C08Q35098302-53C3D6B8-72FD-4873-94A0-D3AD29A52618Q35246995-EE7FDF81-BF95-44B3-8226-F2464665E96AQ35898258-903E96A1-F387-4DF4-9A37-E3696E8AC6FEQ36816243-321E89EB-8CBD-40CE-B55B-1572F2F5C829Q37669484-A84DBA80-01C0-4A9C-BCB9-A0FDA8AB6C03Q38128352-A0A7E9CB-CEFB-4FF3-B48D-5323B049D616Q38232372-FD0BB071-EA61-4F76-8D00-AF6583CBC926Q38232373-50477509-CEA8-4950-A331-BDA1DD460703Q38315670-0426A2B1-D2A8-4029-ADA2-349ACC950623Q38688923-E0BA3A40-6EF8-4408-A91F-F5770ED9CBECQ38797843-5CE9EA4D-9A57-4DFC-ADD8-043DEEE6E597Q38872192-DBD29605-DC9E-4730-A924-B96985EF8631Q38991731-069227D7-866C-42C5-B1E8-F1270DF2CC72Q39012067-7B05D755-B956-48A6-9E21-9DD75590A582Q39359343-7A06957B-DC8A-4CE5-A6BC-5432192E9F21Q39480148-4FC7AEC5-ACBA-4469-B375-858989BE0A61Q41008543-3A361612-12AB-43DE-9F6A-7DA3E3ECD0ECQ44969864-09376529-7D43-4764-B926-DAD18F83A4BBQ49691413-59E51C85-F09D-4C52-8921-300DEB6468FCQ57570780-BF42A638-01FC-492B-9202-E0C57DFB481C
P2860
Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: an analysis of 181 patients of the French ATU compassionate use program.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Long-term outcome and effect o ...... ATU compassionate use program.
@ast
Long-term outcome and effect o ...... ATU compassionate use program.
@en
Long-term outcome and effect o ...... ATU compassionate use program.
@nl
type
label
Long-term outcome and effect o ...... ATU compassionate use program.
@ast
Long-term outcome and effect o ...... ATU compassionate use program.
@en
Long-term outcome and effect o ...... ATU compassionate use program.
@nl
prefLabel
Long-term outcome and effect o ...... ATU compassionate use program.
@ast
Long-term outcome and effect o ...... ATU compassionate use program.
@en
Long-term outcome and effect o ...... ATU compassionate use program.
@nl
P2093
P2860
P50
P356
P1433
P1476
Long-term outcome and effect o ...... ATU compassionate use program.
@en
P2093
Antoine Italiano
Emmanuelle Bompas
Florence Duffaud
François Bertucci
Gauthier Decanter
Jean-Michel Coindre
Loic Chaigneau
Maria Rios
Nadia Badri
P2860
P2888
P356
10.1186/1471-2407-13-64
P407
P577
2013-02-06T00:00:00Z
P5875
P6179
1012626210